The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropeniaLionel D. Lewis, Mark J. Ratain, Antonius A. Miller et al.|Pharmacogenetics and Genomics|2012Cited by 27
THU-144-Ledipasvir/sofosbuvir for 8, 12, or 24 weeks is safe and effective in patients undergoing dialysisWan‐Long Chuang, Alessandra Mangia, Wei‐Wen Su et al.|Journal of Hepatology|2019Cited by 7